Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Adam O'Shea"'
Autor:
Astri Maaland, Adam O'Shea, Helen Heyerdahl, Bergthora Eiriksdottir, Jostein Dahle, Arne Kolstad, Veronique Pascal, Jan Terje Andersen
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose The aim of this study was to explore the β-emitting lutetium-177 labelled anti-CD37 antibody NNV003 (177Lu-NNV003, Humalutin®) for the treatment of non-Hodgkin’s lymphoma in in vitro studies and in animal models. Methods Cytotoxicity of 1
Autor:
Ada H. V. Repetto-Llamazares, Adam O'Shea, Bergthora Eiriksdottir, Roy H. Larsen, Trond Stokke, Marion Masitsa Malenge, Jostein Dahle
Publikováno v:
European Journal of Haematology. 101:522-531
Objectives To investigate the therapeutic potential of the next-generation anti-CD37 radioimmunoconjugate 177 Lu-lilotomab satetraxetan (177 Lu-lilotomab) in combination with the anti-CD20 antibody rituximab for treatment of mice with non-Hodgkin's l
Autor:
Ada H V, Repetto-Llamazares, Marion M, Malenge, Adam, O'Shea, Bergthóra, Eiríksdóttir, Trond, Stokke, Roy H, Larsen, Jostein, Dahle
Publikováno v:
European journal of haematology. 101(4)
To investigate the therapeutic potential of the next-generation anti-CD37 radioimmunoconjugateNude mice with subcutaneous (s.c.) Burkitt's lymphoma Daudi xenografts and SCID mice intravenously (i.v.) injected with Mantle cell lymphoma Rec-1 cells wer
Autor:
Richard J. Looby, Thomas J. McMurry, Manija A. Kazmi, Kenneth E. Carlson, Lynn Haggis, Jay M. Janz, Adam O'Shea, Stephen W. Hunt, Ed McBride, Pallavi Sachdev, Yong Ren, Boris Tchernychev, Thomas P. Sakmar, Qing Deng
Publikováno v:
Proceedings of the National Academy of Sciences. 107:22255-22259
The G protein-coupled receptor (GPCR), chemokine CXC-type receptor 4 (CXCR4), and its ligand, CXCL12, mediate the retention of polymorphonuclear neutrophils (PMNs) and hematopoietic stem and progenitor cells (HSPCs) in the bone marrow. Agents that di
Autor:
Paul D. Ponath, Michael Paglia, Louis Vaickus, Masahide Tone, Reema Gulati, Michael Rosenzweig, Michael Slavonic, Herman Waldmann, Jose F. Ponte, Adam O'Shea
Publikováno v:
Immunology. 130:231-242
Adjuvants, including antibodies to tumour necrosis factor receptor superfamily members, augment immune responses. One member of this family, glucocorticoid-induced tumour necrosis factor receptor (GITR), is expressed at low levels on naive/resting T
Publikováno v:
Blood. 128:4189-4189
Aim: To investigate the therapeutic effect of combined treatment with the anti-CD37 antibody radionuclide conjugate (ARC) 177Lu-satetraxetan-lilotomab (177Lu-p-SCN-Bn-DOTA-HH1, tradename Betalutin®, short name 177Lu-lilotomab) and the anti-CD20 immu
Autor:
Jose F, Ponte, Paul, Ponath, Reema, Gulati, Michael, Slavonic, Michael, Paglia, Adam, O'Shea, Masahide, Tone, Herman, Waldmann, Louis, Vaickus, Michael, Rosenzweig
Publikováno v:
Immunology. 130(2)
Adjuvants, including antibodies to tumour necrosis factor receptor superfamily members, augment immune responses. One member of this family, glucocorticoid-induced tumour necrosis factor receptor (GITR), is expressed at low levels on naive/resting T
Autor:
Olav B. Ryan, Ellen Wang, Jenny Karlsson, Katrine Wickstroem, Adam O'Shea, Joergen Borrebaek, Alan Cuthbertson, Urs B. Hagemann, Roger M. Bjerke
Publikováno v:
Cancer Research. 75:2462-2462
Introduction: The sialoadhesin receptor CD33 is a well-established target in the treatment of acute myeloid leukemia (AML). CD33 is expressed on leukemic blasts in AML and possibly also on leukemic stem cells in some patients (1). Thorium-227, an alp
Autor:
Michale Rosenzweig, Herman Waldmann, Sharon Li, Reema Gulati, Francis Carmody, Michael Slavonic, Adam O'Shea, Michael Paglia
Publikováno v:
Clinical Immunology. 123:S20-S21
Publikováno v:
Clinical Immunology. 123:S33